Khrysos Now Offers Vertically Integrated Full Line of Hemp Derived Products Available for Private Label Brand Development
Khrysos Industries, Inc. a wholly owned subsidiary of Youngevity International, Inc. (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and its newly acquired commercial hemp enterprise announced today that it has added turn key manufacturing solutions to its capabilities in extraction services and end-to-end processing systems. Khrysos is now producing tinctures, balms, bath bombs, creams, ointments, in various potencies. Additionally, Khrysos is offering hemp derived products in capsules and tinctures for pets.
“We are excited to offer turn key product solutions to our suite of services. We believe this expands our competitive advantage within our hemp enterprise by covering all facets of product development to our growing list of clients. The relatively low minimum order quantity capabilities of this operation combined with our comprehensive testing services should offer a unique value proposition for our customers and those seeking to enter this growing market opportunity”, said Dwayne Dundore PhD, President of Khrysos.
“The Khrysos Industries multi-dimensional business model is capable of providing turn key solutions in this dynamic market place,” said Dave Briskie, President and CFO of YGYI, about its wholly owned subsidiary Khrysos Industries. “The vertical integration of our hemp enterprise provides the potential of higher profit contribution as it leverages the other selling segments within our company. We anticipate expanding the capabilities within Khrysos within the coming months and more fully taking advantage of these competencies throughout all facets of our business.”
About Khrysos Industries, Inc.
Khrysos Industries is a leading manufacturer of commercial hemp-based CBD extraction, post processing equipment, and end-to-end processor of CBD isolate, distillate, water soluble Isolate, and water-soluble distillate. Its subsidiary, INX Laboratories provides a broad range of testing services including potency analysis for its supply partners of hemp derived CBD products. Khrysos provides hemp growers, feedstock suppliers, and CBD crude oil producers the use of equipment, intellectual capital, production consultancy, tolling services, and wholesale CBD channel sales capabilities. Khrysos Industries was acquired by Youngevity International (NASDAQ: YGYI) on February 12th, 2019. Be sure to visit us at http://www.khrysosglobal.com, like us on Facebook <https://www.facebook.com/Khrysos-Industries-319252092134375/> and follow us on Twitter, or contact us at .
About Youngevity International, Inc.
YGYI, Inc. (NASDAQ: YGYI), is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity YGYI offers products from the eight top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The Company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.
To receive future press releases via email, please visit: https://ygyi.com/investors/email-alerts/
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions, and includes statements regarding the relatively low minimum order quantity capabilities combined with our comprehensive testing services of our turn key product solutions offering a unique value proposition for our customers, the vertical integration of our hemp enterprise providing the potential of higher profit contribution by leveraging other selling segments and expanding the capabilities within Khrysos within the coming months and more fully taking advantage of these competencies throughout all facets of our business. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, our ability to provide a unique value proposition for our customers with our turn key product solutions, our ability to vertically integrate of our hemp enterprise and generate higher profit contribution by leveraging other selling segments within our company and to expand the capabilities within Khrysos within the coming months and take full advantage of these competencies throughout all facets of our business, our ability to continue our international growth, our ability to continue our coffee segment growth, our ability to leverage our platform and global infrastructure to drive organic growth, our ability to improve our profitability, expand our liquidity, and strengthen our balance sheet, our ability to continue to maintain compliance with the NASDAQ requirements, the acceptance of the omni-direct approach by our customers, our ability to expand our distribution, our ability to add additional products (whether developed internally or through acquisitions), our ability to continue our financial performance and the other factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2018 and our subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.
Contacts:
Youngevity International, Inc.
Dave Briskie
President and Chief Financial Officer
800-982-3189 X6500
